The Howard Hughes Medical Institute (HHMI), the Simons Foundation, and the Bill and Melinda Gates Foundation have announced that MIT faculty members Ed Boyden, Jacquin Niles, Matthew Vander Heiden, and Feng Zhang have been selected as Faculty Scholars. They are among 84 early career scientists from 43 institutions across the United States who are being recognized for their “great potential to make unique contributions to their field.”
This is the first collaboration between HHMI, the Simons Foundation and the Bill and Melinda Gates Foundation. The philanthropies created the new Faculty Scholars Program in response to “growing concern about the significant challenges that early-career scientists are facing.”
Scientists reviewed and evaluated more than 1,400 applicants on their potential for significant research productivity and originality, as judged by their doctoral and postdoctoral work, results from their independent research program, and their future research plans. Through the new program, the three philanthropies will spend about $83 million over five years to support the first cohort of scholars, with each one receiving between $600,000 and $1.8 million to support research endeavors.
The four MIT professors were selected among eligible faculty at more than 220 institutions:
Ed Boyden (HHMI-Simons Faculty Scholar), a professor of biological engineering and brain and cognitive sciences at MIT and a member of MIT’s Media Lab and McGovern Institute for Brain Research, plans to expand his lab’s toolbox for analyzing and engineering brain circuits and other complex biological systems. Most recently, Boyden developed a strategy called expansion microscopy to visualize the nanoscale structure of the brain and other tissues.
Jacquin Niles ’94, ’01 PhD (HHMI-Simons Faculty Scholar), associate professor of engineering in the Department of Biological Engineering, plans to expand his efforts to eliminate malaria by re-engineering the parasite into a drug delivery vehicle. Niles studies functional genetics in the malarial pathogen Plasmodium falciparum, as well as pathogen-host interactions. He’s working toward a clearer understanding of the parasite and disease to provide the scientific foundation for new malarial diagnostics, treatments, and prevention/elimination strategies.
Matthew Vander Heiden (HHMI-Faculty Scholar), an associate professor of biology at the Koch Institute for Integrative Cancer Research at MIT uses mouse models to study cancer cell metabolism. Vander Heiden is working to identify critical steps in metabolic pathways, such as the breakdown of glucose and the production of basic subunits of DNA, that may lead to new cancer therapies.
Feng Zhang (HHMI-Simons Faculty Scholar), an associate professor of biological engineering and brain and cognitive sciences at MIT, an investigator at the McGovern Institute for Brain Research, and a core member of the Broad Institute of MIT and Harvard, is developing tools to better understand nervous system function and disease. Zhang was a pioneer in the development of CRISPR-Cas9, a powerful genome-editing technology with many applications in biomedical research.
“This program will provide these scientists with much needed flexible resources so they can follow their best research ideas,” said HHMI Vice President and Chief Scientific Officer David Clapham.
The above post is reprinted from materials provided by MIT NEWS